Contrast agent dose effects in cerebral dynamic susceptibility contrast magnetic resonance perfusion imaging

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 1, 2009, Pages 52-64

  Alger, Jeffry R ^a   Schaewe, Timothy J ^a   Lai, Tom C ^a   Frew, Andrew J ^a   Vespa, Paul M ^a   Etchepare, Maria ^a   Liebeskind, David S ^a   Saver, Jeffrey L ^a   Kidwell, S Chelsea ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain; Contrast agent; Dose; Dynamic susceptibility contrast; Magnetic resonance imaging; Perfusion

Indexed keywords

GADODIAMIDE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ARTICLE; BRAIN ARTERY; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; HUMAN; NEUROIMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE PATIENT;

BLOOD FLOW VELOCITY; BRAIN; BRAIN ISCHEMIA; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHO-PLANAR IMAGING; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 60349110111     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21613     Document Type: Article

References (39)

1. Ostergaard L. Cerebral perfusion imaging by bolus tracking. Top Magn Reson Imaging 2004;15:3-9.
2. Keston P, Murray AD, Jackson A. Cerebral perfusion imaging using contrast-enhanced MRI. Clin Radiol 2003;58:505-513.
3. Shih LC, Saver JL, Alger JR, et al. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly in-farcted tissue. Stroke 2003;34:1425-1430.
4. Higashida RT, Furlan AJ, Roberts H, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109-e137.
5. Ibaraki M, Shimosegawa E, Toyoshima H, Takahashi K, Miura S, Kanno I. Tracer delay correction of cerebral blood flow with dynamic susceptibility contrast-enhanced MRI. J Cereb Blood Flow Metab 2005;25:378-390.
6. Willats L, Connelly A, Calamante F. Improved deconvolution of perfusion MRI data in the presence of bolus delay and dispersion. Magn Reson Med 2006;56:146-156.
7. Calamante F, Willats L, Gadian DG, Connelly A. Bolus delay and dispersion in perfusion MRI: implications for tissue predictor models in stroke. Magn Reson Med 2006;55:1180-1185.
8. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000;44:466-473.
9. Ibaraki M, Shimosegawa E, Toyoshima H, et al. Effect of regional tracer delay on CBF in healthy subjects measured with dynamic susceptibility contrast-enhanced MRI: comparison with 15O-PET. Magn Reson Med Sci 2005;4:27-34.
10. Salluzzi M, Frayne R, Smith MR. Is correction necessary when clinically determining quantitative cerebral perfusion parameters from multi-slice dynamic susceptibility contrast MR studies? Phys Med Biol 2006;51:407-424.
11. Wu O, Ostergaard L, Koroshetz WJ, et al. Effects of tracer arrival time on flow estimates in MR perfusion-weighted imaging. Magn Reson Med 2003;50:856-864.
12. Weisskoff RM, Chesler D, Boxerman JL, Rosen BR. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993;29:553-558.
13. Boxerman JL, HambergLM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995;34:555-566.
14. Boxerman JL, Rosen BR, Weisskoff RM. Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies. J Magn Reson Imaging 1997;7:528-537.
15. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med 1996;36:726-736.
16. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intra-vascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725.
17. Grandin CB, Bol A, Smith AM, Michel C, Cosnard G. Absolute CBF and CBV measurements by MRI bolus tracking before and after acetazolamide challenge: repeatability and comparison with PETin humans. Neuroimage 2005;26:525-535.
18. Smith AM, Grandin CB, Duprez T, Mataigne F, Cosnard G. Whole brain quantitative CBF, CBV, and MTT measurements using MRI bolus tracking: implementation and application to data acquired from hyperacute stroke patients. J Magn Reson Imaging 2000;12:400-410.
19. Smith AM, Grandin CB, Duprez T, Mataigne F, Cosnard G. Whole brain quantitative CBF and CBV measurements using MRI bolus tracking: comparison of methodologies. Magn Reson Med 2000;43:559-564.
20. Lin W, Celik A, Derdeyn C, et al. Quantitative measurements of cerebral blood flow in patients with unilateral carotid artery occlusion: a PETand MR study. J Magn Reson Imaging 2001;14:659-667.
21. Helenius J, Perkio J, Soinne L, et al. Cerebral hemodynamics in a healthy population measured by dynamic susceptibility contrast MR imaging. Acta Radiol 2003;44:538-546.
22. 2O positron emission tomography in humans. J Cereb Blood Flow Metab 1998;18:935-940.
23. Sakaie KE, Shin W, Curtin KR, McCarthy RM, Cashen TA, Carroll TJ. Method for improving the accuracy of quantitative cerebral perfusion imaging. J Magn Reson Imaging 2005;21:512-519.
24. Shin W, Cashen TA, Horowitz SW, Sawlani R, Carroll TJ. Quantitative CBV measurement from static T1 changes in tissue and correction for intravascular water exchange. Magn Reson Med 2006;56:138-145.
25. ShinW, Horowitz S, Ragin A, Chen Y, Walker M, Carroll TJ. Quantitative cerebral perfusion using dynamic susceptibility contrast MRI: evaluation ofreproducibilityand age- and gender-dependence with fully automatic image postprocessing algorithm. Magn Reson Med 2007;58:1232-1241.
26. Erb G, Benner T, Heiland S, Reith W, Sartor K, ForstingM. [Studies on contrast medium dosage in perfusion-weighted MR imaging]. Rofo 1997;167:599-604. [German]
27. Benner T, Reimer P, Erb G, et al. Cerebral MR perfusion imaging: first clinical application ofa1M gadolinium chelate (Gadovist 1.0) in a double-blinded randomized dose-finding study. J Magn Reson Imaging 2000;12:371-380.
28. Conturo TE, Akbudak E, Kotys MS, et al. Arterial input functions for dynamic susceptibility contrast MRI: requirements and signal options. J Magn Reson Imaging 2005;22:697-703.
29. Kiselev VG. Transverse relaxation effect of MRI contrast agents: a crucial issue for quantitative measurements of cerebral perfusion. J Magn Reson Imaging 2005;22:693-696.
30. Kjolby BF, Ostergaard L, Kiselev VG. Theoretical model of intravas-cular paramagnetic tracers effect on tissue relaxation. Magn Reson Med 2006;56:187-197.
31. LiaTQ, Guang CZ, Ostergaard L, HindmarshT, MoseleyME. Quantification of cerebral blood flow by bolus tracking and artery spin tagging methods. Magn Reson Imaging 2000;18:503-512.
32. Newman GC, Hospod FE, Patlak CS, et al. Experimental estimates of the constants relating signal change to contrast concentration for cerebral blood volume by T2* MRI. J Cereb Blood Flow Metab 2006;26:760-770.
33. van Osch MJ, Vonken EJ, Bakker CJ, Viergever MA. Correcting partial volume artifacts of the arterial input function in quantitative cerebral perfusion MRI. Magn Reson Med 2001;45:477-485.
34. Kidwell CS, Leary M, Lai TC, et al. Calibration of contrast bolus passage magnetic resonance perfusion imaging with xenon computed tomography in human stroke. In: Proceedings of the 21st International Symposium on Cerebral Blood Flow, Metabolism and Function, Calgary, Canada, 2003.
35. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intra-vascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725.
36. Carroll TJ, Rowley HA, Haughton VM. Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology 2003;227:593-600.
37. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
38. Manka C, Traber F, Gieseke J, Schild HH, Kuhl CK. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose. Radiology 2005;234:869-877.
39. Heiland S, Reith W, Forsting M, Sartor K. How do concentration and dosage of the contrast agent affect the signal change in perfu-sion-weighted magnetic resonance imaging? A computer simulation. Magn Reson Imaging 2001;19:813-820.